1. Home
  2. HOTH vs PCLA Comparison

HOTH vs PCLA Comparison

Compare HOTH & PCLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOTH
  • PCLA
  • Stock Information
  • Founded
  • HOTH 2017
  • PCLA 2008
  • Country
  • HOTH United States
  • PCLA Japan
  • Employees
  • HOTH N/A
  • PCLA N/A
  • Industry
  • HOTH Biotechnology: Pharmaceutical Preparations
  • PCLA Building Products
  • Sector
  • HOTH Health Care
  • PCLA Consumer Discretionary
  • Exchange
  • HOTH Nasdaq
  • PCLA Nasdaq
  • Market Cap
  • HOTH 15.6M
  • PCLA 18.6M
  • IPO Year
  • HOTH 2019
  • PCLA 2025
  • Fundamental
  • Price
  • HOTH $1.51
  • PCLA $0.45
  • Analyst Decision
  • HOTH Strong Buy
  • PCLA
  • Analyst Count
  • HOTH 3
  • PCLA 0
  • Target Price
  • HOTH $4.00
  • PCLA N/A
  • AVG Volume (30 Days)
  • HOTH 1.3M
  • PCLA 170.4K
  • Earning Date
  • HOTH 11-11-2025
  • PCLA 01-01-0001
  • Dividend Yield
  • HOTH N/A
  • PCLA N/A
  • EPS Growth
  • HOTH N/A
  • PCLA N/A
  • EPS
  • HOTH N/A
  • PCLA N/A
  • Revenue
  • HOTH N/A
  • PCLA $5,065,197.00
  • Revenue This Year
  • HOTH N/A
  • PCLA N/A
  • Revenue Next Year
  • HOTH N/A
  • PCLA N/A
  • P/E Ratio
  • HOTH N/A
  • PCLA N/A
  • Revenue Growth
  • HOTH N/A
  • PCLA 5.26
  • 52 Week Low
  • HOTH $0.65
  • PCLA $0.37
  • 52 Week High
  • HOTH $3.80
  • PCLA $9.80
  • Technical
  • Relative Strength Index (RSI)
  • HOTH 44.02
  • PCLA 41.11
  • Support Level
  • HOTH $1.49
  • PCLA $0.44
  • Resistance Level
  • HOTH $1.62
  • PCLA $0.48
  • Average True Range (ATR)
  • HOTH 0.14
  • PCLA 0.02
  • MACD
  • HOTH -0.05
  • PCLA 0.01
  • Stochastic Oscillator
  • HOTH 6.11
  • PCLA 11.88

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

Share on Social Networks: